Twitter | Pretraživanje | |
Pretraživanje Osvježi
Seqens_group 3. velj
[SEQENS CDMO] The growth of the generic drug marketplace : A win-win for the industry and patients. Discover the analyse of Laurent Alexandre, Director, Proprietary APIs, at Seqens CDMO on our blog 👇
Reply Retweet Označi sa "sviđa mi se"
Custom Pharma 23 h
At Custom Pharma we are licensed for the manufacture of veterinary medication, we're working on some exciting projects so make sure you follow us and you can click the link below to sign up to our mailing list!
Reply Retweet Označi sa "sviđa mi se"
53Biologics 3 h
could produce much larger volumes at a reduced cost ‼️ we are the leader using . Breaking news:
Reply Retweet Označi sa "sviđa mi se"
Kemwell Biopharma 8 h
Meet the Kemwell team at Annual Biologics Manufacturing Asia 2020 Singapore. To know more details contact the Kemwell team. . . Girish Joshi, PhD, Jaby Jacob, Sanjay Lodha, Rachit Gunderia .
Reply Retweet Označi sa "sviđa mi se"
LSNE Contract Manufacturing 19 h
More expansion news from LSNE!!
Reply Retweet Označi sa "sviđa mi se"
eCare Vault, Inc. 19 h
Reply Retweet Označi sa "sviđa mi se"
Catalent Pharma 20 h
Catalent laying out $315M to snatch another gene therapy
Reply Retweet Označi sa "sviđa mi se"
Michalle Adkins 5. velj
Nice, short summary of 3 keys in selecting a CDMO.
Reply Retweet Označi sa "sviđa mi se"
Kemwell Biopharma 5. velj
Kemwell’s team of experienced scientists strive to develop a robust, efficient, scaled up manufacturing process to deliver consistent product quality. . .
Reply Retweet Označi sa "sviđa mi se"
QuayPharma 4. velj
EXPERTISE CHOSEN TO DELIVER 100% DATA DRIVEN - The strength of Quay is our people. We invest in the best. Only experts with strong scientific backgrounds, years of extensive knowledge underpins the service we deliver. Find out more
Reply Retweet Označi sa "sviđa mi se"
Outsourcing-Pharma 4. velj
's unit drives growth at hospital business
Reply Retweet Označi sa "sviđa mi se"
Kemwell Biopharma 4. velj
Reply Retweet Označi sa "sviđa mi se"
Dan Stanton 3. velj
Breaking: Catalent to buy Orgenesis' biz Masthercell for $315m - story Insider
Reply Retweet Označi sa "sviđa mi se"
Kemwell Biopharma 3. velj
Kemwell Vision is to be a global leader and first-choice CDMO for biologics. . .
Reply Retweet Označi sa "sviđa mi se"
CCRM 31. sij
Our latest blog post is all about understanding reprogramming to generate iPSCs and how to get them ready.
Reply Retweet Označi sa "sviđa mi se"
Fiona Barry 31. sij
This month's BPOR includes the launch of $1.1billion The Center for Breakthrough Medicines for
Reply Retweet Označi sa "sviđa mi se"
Indena 31. sij
New technological investments are a tangible sign of our ability to continue to focus on custom development and manufacturing (), at the same time enhancing the human capital of our operators in terms of dedication and know-how.
Reply Retweet Označi sa "sviđa mi se"
Coripharma 31. sij
Coripharma and Midas to cooperate on sales & marketing for pharmaceutical contract manufacturing of finished dosage forms.
Reply Retweet Označi sa "sviđa mi se"
Vetter Pharma 30. sij
To optimize workflow of customer projects, we align our development service laboratory portfolio under one roof. Further expansion of laboratory space will continue throughout 2020.
Reply Retweet Označi sa "sviđa mi se"
Kemwell Biopharma 30. sij
Reply Retweet Označi sa "sviđa mi se"